Athens Medical Centre (STU:ACS) ROCE %: -0.06% (As of Dec. 2025)

What is Athens Medical Centre ROCE %?

Athens Medical Centre STU:ACS 60 ROCE % is -0.06% as of Dec. 2025. GuruFocus rates STU:ACS with a GF Score™ of 60/100 and a GF Value™ of €1.93. The stock has 8 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Athens Medical Centre's annualized ROCE % for the quarter that ended in Dec. 2025 was -0.06%.

Athens Medical Centre (STU:ACS) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Athens Medical Centre ROCE % Related Terms

Athens Medical Centre ROCE % Historical Data

* Premium members only.

The historical data trend for Athens Medical Centre's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Athens Medical Centre ROCE % Chart

Athens Medical Centre Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

ROCE %

Get a 7-Day Free Trial

9.35

6.63

8.38

5.61

3.27

Athens Medical Centre Semi-Annual Data
	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24	Jun25	Dec25
ROCE %	Get a 7-Day Free Trial															4.25	11.97	-1.02	6.45	-0.06

60GF Score

Athens Medical Centre SA STU:ACS

ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Athens Medical Centre ROCE % Calculation

Athens Medical Centre's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2025 )		(A: Dec. 2024 )		(A: Dec. 2025 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2025 )		(A: Dec. 2024 )		(A: Dec. 2025 )
	=	8.34	/	( ( (495.858 - 230.757)	+	(532.783 - 287.547) )	/ 2 )
	=	8.34	/	( (265.101	+	245.236)	/ 2 )
	=	8.34	/	255.1685
	=	3.27 %

Athens Medical Centre's ROCE % of for the quarter that ended in Dec. 2025 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2025 )		(Q: Jun. 2025 )		(Q: Dec. 2025 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2025 )		(Q: Jun. 2025 )		(Q: Dec. 2025 )
	=	-0.144	/	( ( (526.18 - 269.374)	+	(532.783 - 287.547) )	/ 2 )
	=	-0.144	/	( ( 256.806	+	245.236 )	/ 2 )
	=	-0.144	/	251.021
	=	-0.06 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

Frequently Asked Questions Learn more about ROCE % →

What does a ROCE % of -0.06% mean?

Athens Medical Centre (STU:ACS) has a ROCE % of -0.06% as of Dec. 2025.

Is Athens Medical Centre's ROCE % too high?

Athens Medical Centre's current ROCE % is -0.06%. Overall, Athens Medical Centre has a GF Score™ of 60/100, reflecting its overall financial health beyond just this single metric.

How does Athens Medical Centre's ROCE % compare to HCA and THC?

Athens Medical Centre's ROCE % of -0.06% can be compared against companies in the Healthcare Providers & Services industry. The industry median ROCE % is 6.41. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good ROCE % for a Healthcare Providers & Services company?

The median ROCE % among Healthcare Providers & Services companies is 6.41, based on 648 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high ROCE % mean?

A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median ROCE % is 6.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Athens Medical Centre's current ROCE % is -0.06%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Athens Medical Centre stock overvalued right now?

Athens Medical Centre (STU:ACS) has a current ROCE % of -0.06%. The stock's GF Value™ is €1.93, compared to a current price of €1.59 — trading 17.9% below its estimated fair value. The current ROCE % is -0.06%. Athens Medical Centre's overall GF Score™ is 60/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is ROCE % calculated?

ROCE % is calculated from a company's financial statements. For Athens Medical Centre (STU:ACS), the current ROCE % is -0.06% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Athens Medical Centre (STU:ACS) Overvalued in 2026?

Based on GuruFocus' analysis, Athens Medical Centre stock appears to be undervalued. The current stock price of €1.59 is trading 17.9% below its estimated GF Value™ of €1.93.

Key valuation signals for STU:ACS:

ROCE %: -0.06%
GF Value™: €1.93 vs. price of €1.59 (17.9% below fair value)
GF Score™: 60/100 with 8 warning signs

No single metric tells the full story. See the STU:ACS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Athens Medical Centre Business Description

Industry Healthcare Healthcare Providers & Services

Comparable Companies ATH:VIDAVO HCA XTER:FRE SAU:4013 XKLS:5225 THC BSP:RDOR3 SZSE:300015 DVA NSE:APOLLOHOSP XTER:FME EHC BOM:543220 ENSG ISX:SRAJ BKK:BDMS UHS BOM:532843 ADX:PUREHEALTH ASX:RHC

Other Exchanges IATR:Greece ACS:Germany

Address 5-7 Distomou Street Maroussi, Athens, GRC, 15125

Website https://www.iatriko.gr

Athens Medical Centre SA engages in the provision of healthcare services. It includes medical research and methods of treatment, training, and selection of executives and staff on behalf of the hospitals and importation of medical tools, instruments, machinery, and automated devices for the hospitals. Its offering includes medical services in such specializations as pathology, cardiology, general surgery, plastic and vascular surgery, orthopedic, physiotherapy, ophthalmology, urology, neurosurgery, thoracic, pediatric, dermatology, endocrinology and stomatology. The company operates in Domestic healthcare service, Healthcare service provided abroad (Romania) and Sale of medical tools & sanitary/health equipment segment.

60GF Score

Get the complete analysis for STU:ACS

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.59

Price

€1.93

GF Value

View STU:ACS Analysis

See ROCE % data for all stocks →